Abstract
Growing evidence indicates that some tumor suppressive miRNAs are subject to epigenetic modifications during carcinogenesis. Here, we found that a large miRNA cluster of C19MC was upregulated in HCC cells after combined treatment with DNA methylation inhibitor and histone deacetylase inhibitor. MiR-517a and miR-517c were strikingly different from the remaining 41 miRNAs in C19MC. Ectopic expression of MiR-517a and miR-517c inhibited cell proliferation by blocking G2/M transition, whereas down-regulation of miR-517a and miR-517c facilitated cell growth. We further showed Pyk2 is a target of miR-517a and miR-517c and both the miRNAs are downregulated in HCC samples. These data collectively suggest that down-regulation of both miR-517a and miR-517c contribute to HCC development through regulating Pyk2.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Azacitidine / analogs & derivatives
-
Azacitidine / pharmacology
-
Base Sequence
-
Carcinoma, Hepatocellular / enzymology
-
Carcinoma, Hepatocellular / genetics*
-
Carcinoma, Hepatocellular / pathology
-
Cell Line, Tumor
-
Cell Proliferation*
-
DNA Modification Methylases / antagonists & inhibitors
-
Decitabine
-
Down-Regulation
-
Focal Adhesion Kinase 2 / genetics*
-
Focal Adhesion Kinase 2 / metabolism
-
G2 Phase Cell Cycle Checkpoints
-
Gene Expression Regulation, Enzymologic
-
Gene Expression Regulation, Neoplastic
-
Histone Deacetylase Inhibitors / pharmacology
-
Humans
-
Hydroxamic Acids / pharmacology
-
Liver Neoplasms / enzymology
-
Liver Neoplasms / genetics*
-
Liver Neoplasms / pathology
-
MicroRNAs / genetics*
-
MicroRNAs / metabolism
-
MicroRNAs / physiology
-
Multigene Family
-
Oligonucleotide Array Sequence Analysis
-
RNA Interference
-
Transcriptome
Substances
-
Histone Deacetylase Inhibitors
-
Hydroxamic Acids
-
MIRN517 microRNA, human
-
MicroRNAs
-
trichostatin A
-
Decitabine
-
DNA Modification Methylases
-
Focal Adhesion Kinase 2
-
Azacitidine